Both in Pharmaceuticals
Clene vs Citius Oncology
Over the past year CLNN returned −62.5% and CTOR returned −65.2%; their daily moves had a correlation of 0.05.
CLNN −62.5% CTOR −65.2%Growth of $1, one year, split-adjusted
| Metric | CLNN | CTOR |
|---|---|---|
| Price | $4.10 | $0.5470 |
| Market cap | $58.3M | $57.9M |
| Today | +8.75% | −0.55% |
| 1 month | +5.9% | −35.6% |
| 6 months | −42.7% | −39.8% |
| Year to date | −30.2% | −45.3% |
| 1 year | −65.8% | −67.2% |
| Revenue growth (YoY) | +233.3% | — |
| Gross margin | 60.0% | 67.1% |
| Net margin | −14915.6% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | 8.1× |
| Net cash | -$9.1M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 98.9% |
| Short % of float | 4.6% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).